Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Bioenerg Biomembr ; 53(1): 49-59, 2021 02.
Artigo em Inglês | MEDLINE | ID: mdl-33405048

RESUMO

Glioblastoma (GBM) is one of the most lethal tumor of all human cancers. Due to its poor response to chemotherapy and radiotherapy as well as its high rate of recurrence after treatment, the treatment is still undesired. The identification of potential related genes and bio-markers in the development of GBM could provide some new targets for the treatment of GBM. Our purpose in this study was to evaluate the mission of COL8A2 in GBM. Combined with TCGA, Oncomine databases, CGGA, GEPIA website and qRT-PCR analyses, we found that COL8A2 was up-regulated both in GBM tissues and cells compared to the controls. Moreover, the high COL8A2 expression was associated with the shorter overall survival of patients with GBM. The expression of COL8A2 was also positively correlated with metastasis-associated genes including vimentin, snail, slug, MMP2 and MMP7 according to GEPIA website. Knockdown of COL8A2 could suppress the cell proliferation, cell migration and invasion, whereas the overexpression of COL8A2 significantly expedited these processes. What's more, the outcome of western blot analysis manifested that COL8A2 could induced the expression of vimentin, snail, slug, MMP2 and MMP7. Taken together, COL8A2 activated cell proliferation, cell migration and invasion via raising the relative expression of EMT-related proteins in GBM. Therefore, our investigation suggests the oncogenic role of COL8A2 in GBM and provides a potential application of COL8A2 for GBM therapy.


Assuntos
Membrana Basal/metabolismo , Neoplasias Encefálicas/metabolismo , Colágeno Tipo VIII/metabolismo , Endotélio Corneano/metabolismo , Glioblastoma/metabolismo , Membrana Basal/patologia , Neoplasias Encefálicas/patologia , Endotélio Corneano/patologia , Transição Epitelial-Mesenquimal , Glioblastoma/patologia , Humanos , Transfecção
2.
Mol Med Rep ; 11(4): 3078-86, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25434368

RESUMO

The treatment of glioblastoma, and other types of brain cancer, is limited due to the poor transport of drugs across the blood brain barrier and poor penetration of the blood­brain­tumor barrier. In the present study, cyclic Arginine­Glycine­Aspartic acid­D­Tyrosine­Lysine [c(RGDyK)], that has a high binding affinity to integrin αvß3 receptors, that are overexpressed in glioblastoma cancers, was employed as a novel approach to target cancer by delivering therapeutic molecules intracellularly. The c(RGDyK)/docetaxel polylactic acid­polyethylene glycol (DTX­PLA­PEG) micelle was prepared and characterized for various in vitro and in vivo parameters. The specific binding affinity of the Arginine­Glycine­Aspartic acid (RGD) micelles, to the integrin receptor, enhanced the intracellular accumulation of DTX, and markedly increased its cytotoxic efficacy. The effect of microtubule stabilization was evident in the inhibition of glioma spheroid volume. Upon intravenous administration, c(RGDyK)/DTX­PLA­PEG showed enhanced accumulation in brain tumor tissues through active internalization, whereas non­targeted micelles showed limited transport ability. Furthermore, RGD­linked micelles showed marked anti­glioma activity in U87MG malignant glioma tumor xenografts, and significantly suppressed the growth of tumors without signs of systemic toxicity. In conclusion, the results of the present study suggest that ligand­mediated drug delivery may improve the efficacy of brain cancer chemotherapy.


Assuntos
Antineoplásicos/administração & dosagem , Neoplasias Encefálicas/patologia , Micelas , Peptídeos Cíclicos , Taxoides/administração & dosagem , Animais , Antineoplásicos/farmacocinética , Antineoplásicos/toxicidade , Neoplasias Encefálicas/tratamento farmacológico , Ciclo Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Modelos Animais de Doenças , Docetaxel , Portadores de Fármacos , Sistemas de Liberação de Medicamentos , Liberação Controlada de Fármacos , Glioblastoma/tratamento farmacológico , Glioblastoma/patologia , Humanos , Camundongos , Tamanho da Partícula , Peptídeos Cíclicos/química , Polietilenoglicóis/química , Polímeros/química , Esferoides Celulares , Taxoides/farmacocinética , Taxoides/toxicidade , Carga Tumoral/efeitos dos fármacos , Células Tumorais Cultivadas , Ensaios Antitumorais Modelo de Xenoenxerto
3.
Cell Biochem Biophys ; 72(1): 73-6, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25420533

RESUMO

The objective of this study was to summarize the experience about the protection of the facial nerve in surgery for acoustic neuroma surgery with the aim to improve the retention of facial nerve function and the quality of life. Forty-two patients with acoustic neuroma were recruited from the year 2010 to 2013. Using microsurgical techniques, the tumors were resected through the suboccipital approach over the posterior edge of the sigmoid sinus, and intraoperative electrophysiological monitoring of the facial nerve function was performed. The House-Brackmann (H-B) grading was used to evaluate the facial nerve function evaluation postoperatively. Total tumor resection was achieved in 32 cases, and partial resection in 10 cases, without any intraoperative deaths. Also facial nerves were retained in 35 of 42 cases (83.33 %). One week after surgery, the facial nerve H-B grading was grade I in 8 cases, grade II in 15 cases, grade III in 12 cases, grade IV in 6 cases, and grade V in 1 case. The key to improved protection of the facial nerve during acoustic neuroma surgery includes a complete understanding of the anatomy of the cerebellopontine angle, proper use of microsurgical techniques, and intraoperative electrophysiological monitoring of the status of facial nerve functions to avoid damage to the nerves.


Assuntos
Traumatismos do Nervo Facial/prevenção & controle , Nervo Facial/cirurgia , Microcirurgia/efeitos adversos , Neuroma/cirurgia , Procedimentos Cirúrgicos Operatórios/efeitos adversos , Acústica , Idoso , Estudos de Coortes , Eletrofisiologia/métodos , Feminino , Humanos , Período Intraoperatório , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Neurofisiologia/métodos , Fatores de Tempo , Tomografia Computadorizada por Raios X
4.
Cell Biol Int ; 31(6): 645-8, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17207646

RESUMO

This study concerns the cytogenetic stability of in vitro human bone marrow-derived mesenchymal stem cells (MSCs) in primary culture and after passaging. Bone marrow samples were collected from seven brain malfunction patients involved in autologous MSC transplantation trials. Chromosome preparations from primary MSC cultures and after 3 passages were analyzed by conventional staining and G-banding techniques. All MSCs showed normal diploid karyotypes, 46 XY or 46 XX, without aneuploidy or polyploidy; chromosome structural abnormalities were not detected. The results indicate that the in vitro cultured MSCs retained normal cytogenetics before being transplanted back into the patients.


Assuntos
Células da Medula Óssea/citologia , Análise Citogenética/métodos , Células-Tronco Mesenquimais/citologia , Adulto , Células Cultivadas , Pré-Escolar , Bandeamento Cromossômico , Cromossomos Humanos/genética , Feminino , Humanos , Cariotipagem , Masculino , Metáfase , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...